In this issue briefing, the authors model the economic burden of cardiovascular disease in Colombia—the direct costs of delivering health care services and the indirect costs from productivity losses.
Modelling the Burden of Cardiovascular Disease in Colombia
Modelling the Burden of Cardiovascular Disease in Colombia
Health and Healthcare
$0.00
Cardiovascular disease (CVD) is the leading cause of death globally. Between 2016 and 2035, the number of Colombian adults with CVD will increase almost by two-thirds, going from 980,000 to 1.6 million. Meanwhile, the costs of health care and lost productivity will almost triple, going from US$5 billion in 2016 to US$14 billion by 2035 . Without additional measures to mitigate the impact of population aging and modifiable risk factors, the burden of CVD in Colombia will only continue to grow. This expected increase is driven by demographic changes, mostly population growth and aging.
In Modelling the Burden of Cardiovascular Disease in Colombia, the authors look at the economic burden of CVD from two perspectives: the direct costs of delivering health care services and their impact on the public health care system, and the indirect costs from productivity losses, which impact the broader society and economy.
Customers Who Downloaded This Also Liked
Require an accessible version of this research?
Upon request, Signal49 Research offers accessible versions of research. Please contact us to request your accessible version.
Learn more about our accessibility policies.
Effective January 26, 2026, AERIC Inc./Signal49 Research discontinued use of ‘The Conference Board of Canada’ name, logo and branding, which had been used by AERIC Inc./Signal49 Research under license from The Conference Board, Inc. The Conference Board, Inc. and its licensees, which are not affiliated with Signal49 Research, own all right, title and interest in THE CONFERENCE BOARD name and trademarks in Canada and have the exclusive right to their use in Canada since January 26, 2026.
